Idiopathic pulmonary fibrosis is a chronic lung disease that causes the lung tissue to become thick and stiff, making breathing extremely difficult. Currently, there is no known cause or cure for the condition. Intent on finding a cure, doctors and scientists are working non-stop to find out what causes the disease.
Although the immune system works to fight pathological agents that invade the body, preventing disease, certain immune cells respond in ways that can grievously aggravate health conditions. A prime example is a damaging immune response that causes pulmonary fibrosis (PF) in people infected with the Paracoccidiodes fungi, according to a study published in the journal PLoS One.
Being diagnosed with Pulmonary Fibrosis is not for the faint of heart It is a rough road full of fears, losses and unknowns. Being a good friend to yourself makes this difficult journey a little easier. Hi, I’m Kim Fredrickson, and it is an honor to write this…
In these two short videos from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis shared in September 2015, Dr. Toby Maher from the Royal Brompton Hospital in the UK talks about how patients living with idiopathic pulmonary fibrosis (IPF) can avoid infections. He suggests regularly getting flu and pneumonia vaccinations as well…
Researchers have found, in mice with pulmonary fibrosis and with dominant immune response mediated by immune Th2 cells (T-helper cells), that aerobic exercise reduced lung fibrosis. The study, “Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice,” was published in the journal PLOS One. Fibrosis is the scarring and thickening…
Idiopathic pulmonary fibrosis (IPF) is a rare and chronic lung disease that causes scarring of the lung tissue which leads to difficulties in breathing and a persistent dry cough. Because it only affects only up to 43 people in every 100,000, it is designated as an “orphan disease.” Read…
Recent research suggested that the hormone leptin is a potentially promising plasma biomarker of acute exacerbation (AE) and predictor of survival in patients with idiopathic pulmonary fibrosis (IPF). This is the first report associating leptin levels with IPF or AE-IPF, and could hold great potential to improve disease monitoring. The study…
Pulmonary fibrosis is a lung disease that causes scarring in the tissue of the lungs. It leads to shortness of breath, a persistent dry cough, weight loss, fatigue, and clubbing of the fingers and toes. Read about how you can teach your lungs to improve your breathing. In this…
If you’ve recently been diagnosed with pulmonary fibrosis, there are probably loads of questions running through your mind. Here are some of the most important questions you should ask your doctor according to the American Lung Association. 1. “What is pulmonary fibrosis?” Pulmonary fibrosis (PF) literally means scarring of the lungs.
Patients with idiopathic pulmonary fibrosis (IPF) who demonstrate adequate lung volume still have the same rate of lung volume decline as patients with initially lower volumes, and benefit equally from treatment with Ofev (nintedanib), researchers reported. The study, “Nintedanib in patients with idiopathic pulmonary fibrosis and preserved…
Get regular updates to your inbox.
